Weili Zhu

No ORCID on file · 5 papers in corpus · active 2021-2025

Study types

  • article 3
  • other 1
  • preprint 1

Condition tags

  • adenomyosis 5
  • dysmenorrhea 2
  • mesh:D004412 1
other 2025
Scientific reports ·doi:10.1038/s41598-024-84608-5

This study aimed to elucidate the role of microRNA-92a-3p (miR-92a-3p) in the pathogenesis of adenomyosis. We examined how miR-92a-3p, found in exosomes derived from ectopic lesions, influences the behaviour of endometrial cells, dorsal roo…

article 2024
Open medicine (Warsaw, Poland) ·doi:10.1515/med-2024-0914

Abstract To evaluate the clinical efficacy of etonogestrel subcutaneous implant (ENG-SCI) with that of the levonorgestrel-releasing intrauterine system (LNG-IUD) for adenomyosis treatment. A prospective randomized cohort study was conducted…

preprint 2024
·doi:10.21203/rs.3.rs-3961335/v1
article 2023
JAMA network open ·doi:10.1001/jamanetworkopen.2023.17860

Importance: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. Objective: To determine whether mifepristone…

article 2021
·doi:10.2139/ssrn.3897694